Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells

Citations Over TimeTop 10% of 2013 papers

Abstract

Aberrant regulation of the Wnt/β-catenin pathway has an important role during the onset and progression of colorectal cancer, with over 90% of cases of sporadic colon cancer featuring mutations in APC or β-catenin. However, it has remained a point of controversy whether these mutations are sufficient to activate the pathway or require additional upstream signals. Here we show that colorectal tumours express elevated levels of Wnt3 and Evi/Wls/GPR177. We found that in colon cancer cells, even in the presence of mutations in APC or β-catenin, downstream signalling remains responsive to Wnt ligands and receptor proximal signalling. Furthermore, we demonstrate that truncated APC proteins bind β-catenin and key components of the destruction complex. These results indicate that cells with mutations in APC or β-catenin depend on Wnt ligands and their secretion for a sufficient level of β-catenin signalling, which potentially opens new avenues for therapeutic interventions by targeting Wnt secretion via Evi/Wls. Activating mutations in the Wnt signalling pathway are associated with colon cancer. Here the authors show that tumour cells carrying mutations in APC and β-catenin are still regulated by Wnt ligands, suggesting that Wnt secretion and receptor signalling remains important to control downstream signalling.

Related Papers

• → Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3–independent β-catenin degradation(2003)718 cited
• → Direct Targeting of β-Catenin by a Small Molecule Stimulates Proteasomal Degradation and Suppresses Oncogenic Wnt/β-Catenin Signaling(2016)155 cited
• → β catenin in health: A review(2015)25 cited
• → Protein Kinases Involved in the Regulation of Wnt/β-catenin Signaling(2013)5 cited
• Wnt／β-catenin 信号通路4个基因在子宫内膜异位症中的表达及意义(2014)